Surrogate matrix: opportunities & challenges for tissue sample analysis Review
October 1994. This identifies the validation parameters needed for a variety of analytical methods. The tripartite harmonised ICH Guideline on Methodology (previously coded Q2B) was finalized under Step 4 in November 1996. It extends the Guideline Q2A to include the actual experimental data required, along with the statistical interpretation, for the validation of analytical procedures. The Guideline on Methodology has been incorporated into the Guideline on Text in November 2005 and then renamed Q2(R1), without any changes in the contents of the two Guidelines.
46 Hubert P, Nguyen-Huu JJ, Boulanger B et al. Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal – part I. J. Pharm. Biomed. Anal. 36(3), 579–586 (2004).
47 Hubert P, Nguyen-Huu JJ, Boulanger B et al. Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal – part II. J. Pharm. Biomed. Anal. 45(1), 70–81 (2007).
48 Hubert P, Nguyen-Huu JJ, Boulanger B et al. Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal – part III. J. Pharm. Biomed. Anal. 45(1), 82–96 (2007).
49 Hubert P, Nguyen-Huu JJ, Boulanger B et al. Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal: part IV. Examples of application. J. Pharm. Biomed. Anal. 48(3), 760–771 (2008).
50 Sharma K, Singh RR, Kandaswamy M et al. LC–MS/ MS-ESI method for simultaneous quantitation of three endocannabinoids and its application to rat pharmacokinetic studies. Bioanalysis 3(2), 181–196 (2011).
51 Guo X, Xie P, Chen J et al. Simultaneous quantitative determination of microcystin-LR and its glutathione metabolites in rat liver by liquid chromatography–tandem mass spectrometry. J. Chromatogr. B 963, 54–61 (2014).
52 Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC−MS/MS. Anal. Chem. 75(13), 3019–3030 (2003).
53 Neuschwander-Tetri BA, Roll FJ. Glutathione measurement by high-performance liquid chromatography separation and fluorometric detection of the glutathione- orthophthalaldehyde adduct. Anal. Biochem. 179, 236–241 (1989).
54 Lv W. Investigation of the effects of 24 bio-matrixes on the LC–MS/MS analysis of morinidazole. Talanta 80(3), 1406–1412 (2010).
55 Huang MQ, Lin Z, Weng N. Applications of high- resolution MS in bioanalysis. Bioanalysis 5(10), 1269–1276 (2013).
56 Meyer MR, Helfer AG, Maurer HH. Current position of high-resolution MS for drug quantification in clinical & forensic toxicology. Bioanalysis 6(17), 2275–2284 (2014).
57 Jian W, Edom RW, Weng N. Important considerations for quantitation of small-molecule biomarkers using LC–MS. Bioanalysis 4(20), 2431–2434 (2012).
58 Macneill R, Sangster T, Moussallie M, Trinh V, Stromeyer R, Daley E. Stable-labeled analogues and reliable quantification of nonprotein biomarkers by LC–MS/MS. Bioanalysis 2(1), 69–80 (2010).
59 Kinoshita K, Jingu S, Yamaguchi J-I. A surrogate analyte method to determine D-serine in mouse brain using liquid chromatography-tandem mass spectrometry. Anal. Biochem. 432, 124–130 (2013).
60 Muder RR, Diven WF, Yu VL, Johnson J. Determination of cefoperazone concentration in serum and muscle tissue with a versatile high-pressure liquid chromatographic method. Antimicrob. Agents Chemother. 22(6), 1076–1078 (1982).
61 Saba A, Chiellini G, Frascarelli S et al. Tissue distribution and cardiac metabolism of 3-iodothyronamine. Endocrinology 151(10), 5063–5073 (2010).
62 Guetens G, Prenen H, De Boeck G et al. Imatinib (Gleevec®
, Glivec® ) tumour tissue analysis by measurement
of sediment and by liquid chromatography tandem mass spectrometry. J. Separation Sci. 29(3), 453–459 (2006).
future science group
www.future-science.com
2433
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154